Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Jan-Dec:20:15347354211052520.
doi: 10.1177/15347354211052520.

Pilot Randomized Controlled Trial in Women With Non-Small Cell Lung Cancer to Assess the Feasibility of Delivering Group-Based Psychosocial Care via Videoconference

Affiliations
Randomized Controlled Trial

Pilot Randomized Controlled Trial in Women With Non-Small Cell Lung Cancer to Assess the Feasibility of Delivering Group-Based Psychosocial Care via Videoconference

Kathrin Milbury et al. Integr Cancer Ther. 2021 Jan-Dec.

Abstract

Background: The goal of this pilot randomized controlled trial was to examine the feasibility and acceptability of delivering group-based psychosocial care via videoconference (ie, Zoom) to women with lung cancer undergoing treatment.

Methods: At baseline, women indicated their typical computer and internet use and were then randomized to a group-based intervention that either focused on mindfulness training or psychoeducation. Participants completed 1 Zoom "practice run" prior to starting the 5 group sessions (1 per week). After the last session, they evaluated their experiences with the intervention and its delivery.

Results: With a consent rate of 68%, 54 women (mean age = 66 years; 69% non-Hispanic White; 48% with stage IV disease) were equally randomized. Attendance was high in both arms (session mean, mindfulness = 4.38; education = 4.75; 85% attended all sessions). Across arms, all women rated the program as useful; most preferred group-based delivery (67%) and remote delivery (50%) or had no preference. Although the sample's typical computer use was relatively low (eg, 19% said that they rarely or never use a computer), most women (76%) indicated that Zoom was "very easy" or "easy" to use. After only 0 to 1 attempts, 56% felt comfortable but 26% stated that they never felt comfortable with the technology.

Conclusions: It seems to be feasible to deliver group-based psychosocial interventions via videoconference in women with lung cancer undergoing treatment. Challenges regarding scheduling the group sessions and familiarizing older rather than infrequent computer users with the technology were encountered but resolved over the course of the trial.

Trial registration: ClinicalTrials.gov NCT03731585.

Keywords: NSCLC; feasiblity; mindfulness; online-groups; psychosocial care; women.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Consort chart.
Figure 2.
Figure 2.
Participant experience with Zoom videoconferencing platform. (A) I could easily talk to the other participants using Zoom. (B) I could clearly hear the other participants using Zoom. (C) I believe Zoom sessions were the same as they would have been in-person. (D) I would recommend Zoom to other people. (E) How many attempts did it take for you to feel comfortable using Zoom?

References

    1. Howlader N, Noone AM, Krapcho M, et al., eds. SEER Cancer Statistics Review, 1975-2013. National Cancer Institute; 2013.
    1. Howlader N, Noone AM, Krapcho M, et al., eds. SEER Cancer Statistics Review, 2008-2014. National Cancer Institute; 2018.
    1. Stapelfeld C, Dammann C, Maser E. Sex-specificity in lung cancer risk. Int J Cancer. 2020;146:2376-2382. - PubMed
    1. MacRosty CR, Rivera MP. Lung cancer in women: a modern epidemic. Clin Chest Med. 2020;41:53-65. - PubMed
    1. Ye Y, Jing Y, Li L, et al.. Sex-associated molecular differences for cancer immunotherapy. Nat Commun. 2020;11:1779. - PMC - PubMed

Publication types

Associated data